Dr. Gabriel Ortiz
Pharmacist
4815 Alameda Ave, El Paso
Texas, 79905-2705
915-283-9358 Dr. Gabriel Ortiz is a pharmacist in El Paso, Texas. Patients can reach at 4815 Alameda Ave, El Paso or contact on 915-283-9358. Active license number of Dr. Gabriel Ortiz is 55407 for Pharmacist in Texas.
Dr. Gabriel Ortiz is
Complete Profile:
Dr. Gabriel Ortiz speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
| Name: | Dr. Gabriel Ortiz |
| Specialization: | Pharmacist |
| Gender: | X |
| Location: | 4815 Alameda Ave, El Paso,
Texas, 79905-2705 |
| Phone: | 915-283-9358 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Gabriel Ortiz are as mentioned below.
| NPI Number: | 1417888173 |
| NPI Enumeration Date: | 28 May, 2026 |
| NPI Last Update On: | 28 May, 2026 |
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Gabriel Ortiz are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacist | 55407 | Texas | Primary | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 4815 Alameda Ave,
El Paso, Texas |
| Zip: | 79905-2705 |
| Phone Number: | 915-283-9358 |
Patients can reach Dr. Gabriel Ortiz at
4815 Alameda Ave, El Paso, Texas or can
call on phone at 915-283-9358.
Comments/ Reviews:
Read all the reviews posted for Dr. Gabriel Ortiz below. You may also share your own experience with Dr. Gabriel Ortiz. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 June, 2026.